Neuropeptides
Semax
A synthetic heptapeptide derived from an ACTH fragment.
Early human evidence
- Evidence
- Early clinical
- Status
- Published
Topic authority hub
Neural signaling, stress response, memory models, and the gap between mechanistic and human evidence.
Cognition research spans imaging, behavior, molecular signaling, and disease-specific models. A positive result in one layer does not automatically predict a meaningful outcome in another.
This hub emphasizes study design and species so that human observations remain visibly separate from animal and cell findings.
Neuropeptides
A synthetic heptapeptide derived from an ACTH fragment.
Early human evidence
Neuropeptides
A synthetic tuftsin-related heptapeptide.
Early human evidence
Bioregulatory peptides
A short synthetic tripeptide studied in bioregulation models.
Preclinical foundation
Neuropeptides
A nonapeptide historically investigated in sleep and stress research.
Early human evidence
A resting-state fMRI study comparing 14 Semax-exposed and 10 placebo-exposed healthy volunteers.
A comparative study of Selank and phenazepam in 60 patients with phobic-anxiety and somatoform disorders.
A narrative review of proposed EDR peptide effects on gene expression, protein synthesis, apoptosis, antioxidant systems, and neuronal models.
Neuroprotection
Semax has a wider publication footprint than many catalog neuropeptides, but the literature still separates mechanistic models from human inference.
Cognition
Selank’s strongest catalog value is as a mapped research cluster, not as a single simplified mechanism claim.
Healthy aging
Pinealon is best understood as a short-peptide bioregulator research cluster with limited independent replication.